📰 Mindset Pharma News
Page 5 - Mindset Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mindset Pharma. Real-time updates on events, politics, business and more.
February 27, 2023
In this article, we discuss 10 most promising psychedelic stocks according to analysts.
November 16, 2022
16.11.2022 - PharmAla will be the exclusive global reseller of Mindset’s cGMP psilocybin to appropriately licensed clinical researchersVANCOUVER, British Columbia, Nov. 16, 2022 (GLOBE NEWSWIRE) - PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA), a ... Seite 1
August 31, 2022
The Canadian company said it is increasing its discovery pipeline with three additional “chemically distinct families of highly novel,”...
June 29, 2022
KULR Technology Group Inc announced that it has received a follow-on order for its space-developed phase change material (PCM) heat sink technology from...
June 29, 2022
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) told investors it has developed a new, patent-pending technology, which can deliver its next generation of...
June 29, 2022
KULR Technology Group Inc announced that it has received a follow-on order for its space-developed phase change material (PCM) heat sink technology from...
June 22, 2022
TORONTO, June 22, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”) , a drug discovery and…
May 11, 2022
The UK capital is set to lead the way in the scientific study of the mental-health benefits of psilocybin
May 9, 2022
Startup Clerkenwell Health hopes to help make UK a world leader in psychedelics research
May 4, 2022
Previously relegated to underground communities and raves, ketamine, MDMA and psilocybin are now being studied to develop therapies to treat everything from PTSD to cluster headaches.